Takamitsu Hosoya

This inventor holds 25 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Neurogenesis Research. Top assignees: Jnc Corporation, Tokyo Medical and Dental University, Kyoto University. Active years: 2009-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takamitsu Hosoya. Retrieved from https://idiyas.com/inventor/takamitsu-hosoya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 7)

% Patents Active = 60.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 121(Granted Patents)

Location History:

Yokohoma, JP (2011)
Kanagawa, JP (2009 - 2014)
Bunkyo-ku, JP (2014 - 2021)
Tokyo, JP (2013 - 2022)

Company Filing History:

Tokyo Medical and Dental University

Tokyo Institute of Technology

9. 2 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2009-2022

Loading Chart...

Areas of Expertise:

Neurogenesis

Anticancer Agents

Pharmaceutical Composition

Biological Molecule

Transcription Activity

Autophagy Induction

Viral Activity

Protein Phosphorylation

Coelenterazine Analog

Screening Method

Pain-Related Compounds

Neuropsychological Disorder

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11318126 - Composition for activating neurogenesis (2022-05-03),

2. 10954222 - Benzothiophene compound, alternative autophagy-inducing agent and anticancer agent including the compound as active ingredient, and method for screening for compound having anticancer activity (2021-03-23),

3. 10017524 - Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor (2018-07-10),

4. 9879014 - Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of disease (2018-01-30),

5. 9745323 - Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor (2017-08-29),

6. 9745275 - Pain-related compound and medical composition (2017-08-29),

7. 9645128 - Substituted imidazo[1,2-A]pyrazines for measuring a transcription activity (2017-05-09),

8. 9422294 - Cyclic compound, method for producing cyclic compound, and method for modifying biological molecule (2016-08-23),

9. 9346767 - Substituted pyrazines and a process for producing the same (2016-05-24),

10. 9151739 - Coelenterazine analogs and manufacturing method thereof (2015-10-06),

11. 9075058 - Coelenterazine analogues and coelenteramide analogues (2015-07-07),

12. 9056840 - Coelenterazine analogues and coelenteramide analogues (2015-06-16),

13. 8975403 - Process for producing substituted benzo[F]imidazo[1,2-A]quinoxalin-3(11H)-ones (2015-03-10),

14. 8901312 - Cyclic compound, method for producing cyclic compound, and method for modifying biological molecule (2014-12-02),

15. 8883432 - Coelenterazine analogues and coelenteramide analogues (2014-11-11),

Title: Innovations and Patents of Takamitsu Hosoya

Introduction

Takamitsu Hosoya is a prominent inventor based in Tokyo, Japan, recognized for his significant contributions to the fields of neurogenesis and cancer research. With an impressive portfolio of 25 patents, his work reflects innovative approaches to tackling critical health challenges.

Latest Patents

Among his notable inventions is a composition aimed at activating neurogenesis. This innovative composition comprises a compound that inhibits the phosphorylation activity of a protein kinase, facilitating the prevention and treatment of central and peripheral nervous system disorders. Another recent patent focuses on a benzothiophene compound that serves as an alternative autophagy-inducing agent and anticancer agent. This invention offers efficient screening methods for compounds with anticancer activity, promoting advances in cancer treatment.

Career Highlights

Takamitsu Hosoya has collaborated with notable institutions, including JNC Corporation and the National University Corporation Tokyo Medical and Dental University. His tenure at these organizations has enriched his research, allowing for the development of groundbreaking inventions that contribute to health science.

Collaborations

He has worked alongside esteemed colleagues such as Satoshi Inouye and Suguru Yoshida, fostering a collaborative environment that encourages innovation and progress in their respective fields.

Conclusion

Takamitsu Hosoya's innovative spirit and dedication to research in neurogenesis and cancer therapy not only enhance scientific understanding but also pave the way for future developments in medical treatments. With ongoing research and a strong portfolio of patents, he remains a key figure in the advancement of health sciences.

Profile summary based on public USPTO records.